Login
$PCOR
$77.55 +$0.00 (0.0%) After hours

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts
Q3 FY2026
As of Sep 30, 2026
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Assets
Current assets
Cash and cash equivalents
Marketable securities (amortized cost of [in-cell link] and [in-cell link] at [in-cell link] and [in-cell link], respectively)
Accounts receivable, net of allowance for credit losses of [in-cell link] and [in-cell link] at [in-cell link] and [in-cell link], respectively
Contract cost asset, current
Prepaid expenses and other current assets
Total current assets
Marketable securities, non-current (amortized cost of [in-cell link] and [in-cell link] at [in-cell link] and [in-cell link], respectively)
Capitalized software development costs, net
Intangible assets, net
Software, Internally Developed and Purchased
All Intangible Assets, Excluding Software
Total intangible assets, net
Property and equipment, net
Right of use assets - finance leases
Right of use assets - operating leases
Contract cost asset, non-current
Goodwill
Other assets
Total assets
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable
Accrued expenses
Deferred revenue, current
Other current liabilities
Total current liabilities
Deferred revenue, non-current
Finance lease liabilities, non-current
Operating lease liabilities, non-current
Convertible notes, non-current
Other liabilities, non-current
Total liabilities
Preferred stock, shares authorized (in shares)
Preferred stock, par value (in dollars per share)
Stockholders’ equity
Preferred stock, $0.0001 par value, 100,000,000 shares authorized at [in-cell link] and [in-cell link]; [in-cell link] shares issued and outstanding at [in-cell link] and [in-cell link].
Common stock, $0.0001 par value, 1,000,000,000 shares authorized at [in-cell link] and [in-cell link] ; [in-cell link] and [in-cell link] shares issued and outstanding at [in-cell link] and [in-cell link], respectively.
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support